Celldex Therapeutics, Inc. is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

View all →   RSSRecent Releases
May 13, 2015 Celldex Therapeutics to Present Data from the ReACT Study at 2015 ASCO Annual Meeting
Apr 29, 2015 Celldex Reports First Quarter 2015 Results
What's New

2012 Form 10-K

More →Upcoming Events
May 30, 2015
9:00 AM ET
Glembatumumab Vedotin Poster Presentation at 2015 ASCO Annual Meeting
May 30, 2015
9:00 AM ET
CDX-301 Poster Presentation at 2015 ASCO Annual Meeting
May 31, 2015
9:00 AM ET
ReACT Study Oral Presentation at 2015 ASCO Annual Meeting
Featured Financial Reports
Filing Date Title Type Size
Apr 29, 2015 Form 10-Q View HTML View PDF 312.8 KB Add to Briefcase
Feb 24, 2015 Form 10-K View HTML View PDF 1.1 MB Add to Briefcase
Add to Briefcase = add file to Briefcase